The mechanism in the diversity and amplification of mucosal immune system -Clinical application of mucosal vaccine-

粘膜免疫系统多样性和扩增的机制-粘膜疫苗的临床应用-

基本信息

  • 批准号:
    14370548
  • 负责人:
  • 金额:
    $ 8.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

1.Immune responses against Haemophilus influenzae(Hi) P6.Recombinant P6(rP6) and nanosphere were coupled and intra-nasally administered to mice. Although P6-specific serum IgM and IgG levels were increased, secretory IgA was not induced in external secretions, indicating the low antigenesity of rP6 as mucosal antigen.2.Mucosal immune responses against phosphorylcholine(PC).PC is contained in all Gram-positive and -negative bacteria. However, the antigenesity of PC is not yet clarified. When PC was intra-nasally administered to mice, systemic as well as mucosal immune responses were induced without using any mucosal adjuvant such as cholera toxin. Moreover, the antibodies induced by PC were cross-reactive with several different strains of Hi and Streptococcus pneumoniae. Those results suggest that PC might be a candidate of mucosal vaccine with broad spectrum.3.Inhibition of type I allergy by immunization with PC.Mucosal vaccine frequently induces type I allergy by producing IgE. However, when PC was intra-nasally or intra-peritoneally administered to mice, the production of IgE was significantly reduced. Further, splenic helper T cells isolated from immunized mice with PC produced much less IL-4 compared with the controls. Those findings suggest the efficacy and the safety of PC as a promising mucosal vaccine.
1.针对流感嗜血杆菌(Hi)P6的免疫反应。将重组P6(rP6)与纳米球偶联并给小鼠鼻内给药。虽然P6特异性血清IgM和IgG水平升高,但外分泌物中未诱导分泌型IgA,表明rP6作为粘膜抗原的抗原性较低。2.针对磷酸胆碱(PC)的粘膜免疫反应。PC存在于所有革兰氏阳性和阴性细菌中。然而,PC的抗原性尚未明确。当 PC 鼻内给予小鼠时,在不使用任何粘膜佐剂(例如霍乱毒素)的情况下,诱导了全身和粘膜免疫反应。此外,PC诱导的抗体与几种不同的Hi菌株和肺炎链球菌有交叉反应。这些结果表明PC可能是广谱粘膜疫苗的候选者。3.PC免疫抑制I型变态反应。粘膜疫苗经常通过产生IgE诱导I型变态反应。然而,当PC经鼻内或腹膜内给予小鼠时,IgE的产生显着减少。此外,与对照组相比,从接受 PC 免疫的小鼠中分离出的脾脏辅助 T 细胞产生的 IL-4 少得多。这些发现表明 PC 作为一种有前途的粘膜疫苗的有效性和安全性。

项目成果

期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The role of allergic rhinitis in upper respiratory tract inflammatory diseases.
过敏性鼻炎在上呼吸道炎症性疾病中的作用。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y.Kurono;S.Matsune et al.
  • 通讯作者:
    S.Matsune et al.
NALTの形成と機能発現におけるLTとNIKの役割
LT 和 NIK 在 NALT 形成和功能表达中的作用
The role of nuclear factor-κB in interleukin-8 expression by human adenoidal fibroblasts.
核因子-κB 在人腺样成纤维细胞表达白细胞介素 8 中的作用。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takaki M.;Ushikai M.;Deguchi K.;Nishmoto K.;Matsune S.;Kurono Y.
  • 通讯作者:
    Kurono Y.
Norimitsu Tanaka: "Immune responses of palatine tonsil against bacterial antigens."International Congress Series. 1257. 141-144 (2003)
Norimitsu Tanaka:“腭扁桃体对细菌抗原的免疫反应。”国际大会系列。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Initiation of NALT organogenesis is independent of the IL-7R, LTβR, and NIK signaling pathways but requires the Id2 gene and CD3-CD4+CD45+ cells
  • DOI:
    10.1016/s1074-7613(02)00339-4
  • 发表时间:
    2002-07-01
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Fukuyama, S;Hiroi, T;Kiyono, H
  • 通讯作者:
    Kiyono, H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KURONO Yuichi其他文献

KURONO Yuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KURONO Yuichi', 18)}}的其他基金

Sublingual immunization-A new vaccination route for mucosa immunity and protection of upper respiratory infection
舌下免疫——粘膜免疫和上呼吸道感染防护的新接种途径
  • 批准号:
    20390443
  • 财政年份:
    2008
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel nasal vaccine having wide spectrum activity for upper respiratory infections
开发一种针对上呼吸道感染具有广谱活性的新型鼻疫苗
  • 批准号:
    17390463
  • 财政年份:
    2005
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Study on Cytokine Production of Helper T cell and its Therapeutic Effect in Allergic Rhinitis
辅助性T细胞产生细胞因子及其治疗变应性鼻炎的研究
  • 批准号:
    11671693
  • 财政年份:
    1999
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of mucosal vaccine against upper respiratory tract infections
粘膜疫苗在上呼吸道感染中的应用
  • 批准号:
    11557126
  • 财政年份:
    1999
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Mechanisms of Mucosal Immune Responses in Adenoid and Tonsil (NALT)
腺样体和扁桃体 (NALT) 粘膜免疫反应的机制
  • 批准号:
    09470374
  • 财政年份:
    1997
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Immunological Treatment against Upper Respiratory Tract Infection caused by Haemophilus influenzae ; The Roleof Mucosal Immunity
流感嗜血杆菌引起的上呼吸道感染的免疫治疗;
  • 批准号:
    06671724
  • 财政年份:
    1994
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Identifying the correlates of protection against Streptococcus pneumoniae respiratory tract infection using a human challenge model
使用人体挑战模型确定预防肺炎链球菌呼吸道感染的相关性
  • 批准号:
    MR/Z503721/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Research Grant
The impact of thermally-regulated cell wall modifications on Streptococcus pneumoniae pathogenesis
热调节细胞壁修饰对肺炎链球菌发病机制的影响
  • 批准号:
    MR/X009130/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Research Grant
Cardiomyocyte self-defense against Streptococcus pneumoniae
心肌细胞对抗肺炎链球菌的自我防御
  • 批准号:
    10639102
  • 财政年份:
    2023
  • 资助金额:
    $ 8.77万
  • 项目类别:
ISS: Exploiting the Space Environment to Dissect the Molecular Basis of Streptococcus pneumoniae (Spn) Cardiotoxicity”
国际空间站:利用太空环境剖析肺炎链球菌 (Spn) 心脏毒性的分子基础 —
  • 批准号:
    2223072
  • 财政年份:
    2023
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Standard Grant
Understanding how penicillin resistance develops in Streptococcus pneumoniae clinical populations
了解肺炎链球菌临床人群中青霉素耐药性如何发展
  • 批准号:
    2902003
  • 财政年份:
    2023
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Studentship
Small RNA based control of zinc homeostasis in Streptococcus pneumoniae
基于小RNA的肺炎链球菌锌稳态控制
  • 批准号:
    10625448
  • 财政年份:
    2022
  • 资助金额:
    $ 8.77万
  • 项目类别:
THE IMPACT OF ADVANCED AGE AND SEX ON HUMORAL IMMUNITY TO STREPTOCOCCUS PNEUMONIAE
高龄和性别对肺炎链球菌体液免疫的影响
  • 批准号:
    10532071
  • 财政年份:
    2022
  • 资助金额:
    $ 8.77万
  • 项目类别:
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequences
肺炎链球菌全基因组的进化本质及其机制和进化后果
  • 批准号:
    10503286
  • 财政年份:
    2022
  • 资助金额:
    $ 8.77万
  • 项目类别:
TNF impairs macrophage killing of Streptococcus pneumoniae
TNF 损害巨噬细胞对肺炎链球菌的杀伤作用
  • 批准号:
    475472
  • 财政年份:
    2022
  • 资助金额:
    $ 8.77万
  • 项目类别:
    Studentship Programs
Utilization of the adjuvant effect of CRM197 protein to develop a trivalent protein-vaccine against Streptococcus pneumoniae infections
利用CRM197蛋白的佐剂作用开发抗肺炎链球菌感染的三价蛋白疫苗
  • 批准号:
    10552114
  • 财政年份:
    2022
  • 资助金额:
    $ 8.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了